03.08.24
Universal Display Corporation announced that Dr. Nigel Brown and Dr. Joan Lau have joined the company’s Board of Directors, effective March 4, 2024. The addition of these new directors expands UDC’s Board to ten members.
“I am pleased to welcome Nigel and Joan to the Board,” said Steven V. Abramson, president and CEO of Universal Display and a member of the Board. “Nigel adds a wealth of business innovation, technical knowledge and corporate strategic planning expertise to our Board.
“Joan brings over two decades of extensive scientific and business acumen as well as invaluable leadership experience to UDC,” added Abramson. “We believe that their deep research and development backgrounds and experience with growth companies will enhance the capabilities of our Board as we explore and execute on opportunities in the global OLED industry and beyond.”
Dr. Brown has more than 25 years of experience in leadership and strategy in the pharmaceutical, biotechnology and contract research industries. Dr. Brown is the founder and CEO of Princeton Healthcare Advisory, LLC, an advisory firm.
Dr. Lau has more than 20 years of experience in executive leadership and business development for biopharmaceutical, biotechnology and R&D-focused companies. Dr. Lau is the co-founder and CEO of Spirovant (previously called Talee Bio), a gene therapy company developing treatments and cures for respiratory diseases including cystic fibrosis. Dr. Lau is also an adjunct professor and trustee at the University of Pennsylvania.
“I am pleased to welcome Nigel and Joan to the Board,” said Steven V. Abramson, president and CEO of Universal Display and a member of the Board. “Nigel adds a wealth of business innovation, technical knowledge and corporate strategic planning expertise to our Board.
“Joan brings over two decades of extensive scientific and business acumen as well as invaluable leadership experience to UDC,” added Abramson. “We believe that their deep research and development backgrounds and experience with growth companies will enhance the capabilities of our Board as we explore and execute on opportunities in the global OLED industry and beyond.”
Dr. Brown has more than 25 years of experience in leadership and strategy in the pharmaceutical, biotechnology and contract research industries. Dr. Brown is the founder and CEO of Princeton Healthcare Advisory, LLC, an advisory firm.
Dr. Lau has more than 20 years of experience in executive leadership and business development for biopharmaceutical, biotechnology and R&D-focused companies. Dr. Lau is the co-founder and CEO of Spirovant (previously called Talee Bio), a gene therapy company developing treatments and cures for respiratory diseases including cystic fibrosis. Dr. Lau is also an adjunct professor and trustee at the University of Pennsylvania.